(19)
(11) EP 3 541 802 A1

(12)

(43) Date of publication:
25.09.2019 Bulletin 2019/39

(21) Application number: 17797841.8

(22) Date of filing: 03.11.2017
(51) International Patent Classification (IPC): 
C07D 401/14(2006.01)
A61K 31/4439(2006.01)
C07D 413/04(2006.01)
 A61K 31/4196(2006.01)
C07D 401/04(2006.01)
(86) International application number:
PCT/US2017/059828
(87) International publication number:
WO 2018/093576 (24.05.2018 Gazette 2018/21)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 16.11.2016 US 201662422963 P

(71) Applicant: Amgen Inc.
Thousand Oaks, California 91320-1799 (US)

(72) Inventors:
  • CHEN, Yinhong
    Hayward California 94542 (US)
  • DEBENEDETTO, Mikkel V.
    Shrewsburry, Massachusetts 01545 (US)
  • DRANSFIELD, Paul John
    Arlington Massachusetts 02474 (US)
  • HARVEY, James S.
    Arlington, Massachusetts 02474 (US)
  • HOUZE, Jonathan
    Cambridge, Massachusetts 02139 (US)
  • KHAKOO, Aarif Yusuf
    Woodside California 94062 (US)
  • LAI, Su-Jen
    Cambridge, Massachusetts 02139 (US)
  • MA, Zhihua
    Lexington Massachusetts 02421 (US)
  • NISHIMURA, Nobuko
    West Hills California 91304 (US)
  • PATTAROPONG, Vatee
    Bedford Massachusetts 01730 (US)
  • SWAMINATH, Gayathri
    Brisbane California 94005 (US)
  • YEH, Wen-Chen
    Belmont California 94002 (US)
  • RAMSDEN, Philip Dean
    Acton Massachusetts 01720 (US)
  • SHARMA, Ankit
    Quincy Massachusetts 02169 (US)

(74) Representative: Grünecker Patent- und Rechtsanwälte PartG mbB 
Leopoldstraße 4
80802 München
80802 München (DE)

   


(54) ALKYL SUBSTITUTED TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR